MTOR and hepatocellular carcinoma: Therefore, a reduced IL-6/leptin-evoked signaling capacity via Akt/mTOR/eIF4E axis could contribute to reduced HCC burden in hepatic LEPR and IL-6Rα double-deficient mice.